Orchid Pharma quarterly results and financials

Orchid Pharma (ORCHPHARMA)₹884.00−0.29%(9 Nov 2026 close)Pharmaceuticals

Key facts

In the Jun 2026 quarter (consolidated), Orchid Pharma reported sales of ₹303 Cr, up 15.5% from Jun 2025, and net profit of ₹3.23 Cr. For the year to Mar 2026, sales were ₹1,229 Cr and net profit ₹10.02 Cr.

Sales (Jun 2026): ₹303 Cr
Net profit (Jun 2026): ₹3.23 Cr
Sales (FY Mar 2026): ₹1,229 Cr
Net profit (FY Mar 2026): ₹10.02 Cr
EPS (Jun 2026): ₹0.64
Borrowings (Mar 2026): ₹363 Cr

Company filings, consolidated accounts; latest reported quarter Jun 2026

Orchid Pharma quarterly results

₹ crore unless stated; each column is a quarter.

Orchid Pharma Quarterly results
	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	198	220	217	244	222	217	237	262	193	207	367	303
Expenses	176	186	189	213	193	191	210	269	195	206	339	291
Operating Profit	23.23	35.24	28.82	32.36	30.20	26.28	27.87	−5.63	−1.46	1.55	30.06	13.94
OPM %	11.8%	16.1%	13.4%	13.4%	13.7%	12.2%	11.8%	−2.1%	−0.8%	0.8%	8.2%	4.6%
Other Income	8.37	7.63	13.37	7.58	7.53	8.50	3.91	11.58	10.78	−1.51	7.56	1.84
Interest	3.79	3.52	3.45	3.49	3.32	3.78	3.90	2.27	3.72	3.16	1.95	2.22
Depreciation	7.82	9.25	8.40	8.42	8.62	8.59	8.84	10.51	8.88	9.02	10.88	10.92
Profit before tax	19.96	30.14	30.33	28.05	25.86	22.41	19.04	−6.87	−3.32	−12.12	24.80	2.64
Tax %	0.0%	0.0%	−10.3%	−0.5%	0.0%	0.0%	−0.2%	0.0%	0.0%	0.0%	0.0%	2.7%
Exceptional items	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	−6.98	0.00	0.00
Net Profit	19.82	29.49	33.01	29.38	27.29	20.81	22.34	−5.70	−5.73	−12.62	25.89	3.23
EPS (Rs)	3.91	5.81	6.51	5.80	5.38	4.11	4.40	−1.13	−1.14	−2.50	5.10	0.64

Orchid Pharma profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Orchid Pharma Profit and loss
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	871	795	681	598	483	449	559	665	817	919	1,229	1,070
Expenses	705	796	660	613	516	422	506	582	710	806	1,201	1,031
Operating Profit	170	2.99	23.92	−11.96	−30.86	28.91	54.80	83.73	111	117	33.89	44.09
OPM %	20.1%	0.4%	3.6%	−2.0%	−6.0%	7.0%	10.1%	13.1%	14.1%	13.1%	2.7%	4.1%
Other Income	−28.02	−59.09	20.03	218	24.03	15.01	67.11	52.03	31.02	27.01	29.01	18.67
Interest	293	345	309	6.98	5.98	51.81	32.87	32.87	16.92	14.93	8.97	11.05
Depreciation	145	141	133	130	118	109	86.87	54.87	32.92	34.90	42.93	39.70
Profit before tax	−295	−543	−398	68.89	−131	−117	1.99	47.90	91.83	95.72	9.98	12.00
Tax %	−6.0%	−9.0%	−12.0%	0.0%	0.0%	0.0%	0.0%	0.0%	−3.0%	0.0%	−2.0%	—
Exceptional items	−52.82	−85.69	0.00	200	0.00	1.99	0.99	39.86	0.00	0.00	−6.98	−6.98
Net Profit	−279	−495	−353	69.15	−131	−117	−2.01	46.06	92.15	100	10.02	10.77
EPS (Rs)	−31.43	−55.83	−39.73	7.81	−32.16	−28.59	−0.49	11.38	18.21	19.70	1.97	2.10
Dividend payout %	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—

Orchid Pharma balance sheet

₹ crore, at each year end.

Orchid Pharma Balance sheet
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	85.21	89.12	89.22	89.20	89.22	41.03	41.02	41.11	41.08	51.05	51.07	51.09
Reserves	244	−40.03	−556	−881	−793	724	611	606	647	1,117	1,216	1,236
Borrowings	3,208	3,210	3,103	3,199	3,228	565	452	268	331	135	175	363
Other Liabilities	519	595	613	712	548	127	131	194	204	248	245	260
Total Liabilities	4,056	3,855	3,250	3,119	3,073	1,457	1,235	1,109	1,222	1,551	1,686	1,908
Fixed Assets	1,794	1,637	1,497	1,386	1,255	857	669	584	572	620	633	691
CWIP	282	280	288	272	278	25.98	6.99	9.99	45.99	30.97	80.99	341
Investments	0.99	0.99	0.99	0.99	0.00	0.00	14.98	44.96	43.99	45.93	49.96	52.93
Other Assets	1,980	1,937	1,465	1,462	1,538	574	543	470	559	855	923	824
Inventories	252	242	211	194	170	142	153	173	229	264	325	256
Trade receivables	256	309	165	120	120	67.84	136	171	214	195	241	263
Cash & equivalents	392	316	258	307	327	175	20.08	8.03	31.11	268	181	83.29
Total Assets	4,056	3,855	3,250	3,119	3,073	1,457	1,235	1,109	1,222	1,551	1,686	1,908

Orchid Pharma cash flow

₹ crore, for each year.

Orchid Pharma Cash flow
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	−369	212	401	8.99	11.99	80.93	23.97	91.92	17.97	126	18.99	101
Cash from investing activity	1,329	−0.99	−175	−27.92	44.86	166	66.76	113	−30.92	−311	−26.92	−284
Cash from financing activity	−596	−286	−465	32.98	0.00	−250	−165	−217	30.98	167	24.97	170
Net cash flow	368	−76.05	−240	15.01	57.08	−2.01	−74.12	−11.01	18.01	−19.03	18.01	−14.02
Capex	83.69	0.99	8.97	5.98	6.98	3.98	0.99	13.94	84.72	64.72	149	382
Free cash flow	961	210	391	2.99	4.98	76.68	22.91	237	−7.97	60.81	−131	−272
CFO / OP %	−102.1%	124.0%	13,628.0%	67.0%	−138.0%	−226.0%	63.0%	173.0%	21.9%	112.9%	17.0%	293.0%

Orchid Pharma ratios

Working-capital days and returns, by year.

Orchid Pharma Ratios
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	54	130	75	64	73	51	110	111	118	87	96	78
Inventory days	119	221	197	203	215	255	245	202	218	200	220	112
Days payable	147	342	403	375	382	183	177	196	166	174	150	100
Cash conversion cycle	26	9	−130	−108	−94	123	179	117	170	113	166	90
Working capital days	−49	−168	−500	−876	−1,158	166	302	97	54	118	135	95
ROCE %	1.0%	1.0%	−4.0%	−4.0%	−5.0%	−6.0%	−5.0%	−2.0%	5.0%	8.9%	7.9%	2.0%

Orchid Pharma: frequently asked questions

What are the latest quarterly results of Orchid Pharma?

For the Jun 2026 quarter, Orchid Pharma reported sales of ₹303 Cr, up 15.5% year on year and net profit of ₹3.23 Cr. The operating margin was 4.6%.

What is the annual revenue of Orchid Pharma?

Orchid Pharma's sales for the year to Mar 2026 were ₹1,229 Cr; over the last twelve months they were ₹1,070 Cr.

What is the net profit of Orchid Pharma?

Net profit for the year to Mar 2026 was ₹10.02 Cr, and ₹10.77 Cr over the last twelve months. Earnings per share over the same trailing period were ₹2.10.

How much debt does Orchid Pharma have?

Orchid Pharma reported borrowings of ₹363 Cr at Mar 2026, against cash and equivalents of ₹83.29 Cr.

What is the free cash flow of Orchid Pharma?

Cash from operations was ₹101 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹272 Cr.

Loading…